Noncanonical effector functions of the T-memory-like T-PLL cell are shaped by cooperative TCL1A and TCR signaling
S Oberbeck,A Schrader,K Warner,D Jungherz,G Crispatzu,J von Jan,M Chmielewski,A Ianevski,H H Diebner,P Mayer,A Kondo Ados,L Wahnschaffe,T Braun,T A Müller,P Wagle,A Bouska,T Neumann,S Pützer,L Varghese,N Pflug,M Thelen,J Makalowski,N Riet,H J M Göx,G Rappl,J Altmüller,M Kotrová,T Persigehl,G Hopfinger,M L Hansmann,H Schlößer,S Stilgenbauer,J Dürig,D Mougiakakos,M von Bergwelt-Baildon,I Roeder,S Hartmann,M Hallek,R Moriggl,M Brüggemann,T Aittokallio,J Iqbal,S Newrzela,H Abken,M Herling
DOI: https://doi.org/10.1182/blood.2019003348
IF: 20.3
2020-12-10
Blood
Abstract:T-cell prolymphocytic leukemia (T-PLL) is a poor-prognostic neoplasm. Differentiation stage and immune-effector functions of the underlying tumor cell are insufficiently characterized. Constitutive activation of the T-cell leukemia 1A (TCL1A) oncogene distinguishes the (pre)leukemic cell from regular postthymic T cells. We assessed activation-response patterns of the T-PLL lymphocyte and interrogated the modulatory impact by TCL1A. Immunophenotypic and gene expression profiles revealed a unique spectrum of memory-type differentiation of T-PLL with predominant central-memory stages and frequent noncanonical patterns. Virtually all T-PLL expressed a T-cell receptor (TCR) and/or CD28-coreceptor without overrepresentation of specific TCR clonotypes. The highly activated leukemic cells also revealed losses of negative-regulatory TCR coreceptors (eg, CTLA4). TCR stimulation of T-PLL cells evoked higher-than-normal cell-cycle transition and profiles of cytokine release that resembled those of normal memory T cells. More activated phenotypes and higher TCL1A correlated with inferior clinical outcomes. TCL1A was linked to the marked resistance of T-PLL to activation- and FAS-induced cell death. Enforced TCL1A enhanced phospho-activation of TCR kinases, second-messenger generation, and JAK/STAT or NFAT transcriptional responses. This reduced the input thresholds for IL-2 secretion in a sensitizer-like fashion. Mice of TCL1A-initiated protracted T-PLL development resembled such features. When equipped with epitope-defined TCRs or chimeric antigen receptors, these Lckpr-hTCL1Atg T cells gained a leukemogenic growth advantage in scenarios of receptor stimulation. Overall, we propose a model of T-PLL pathogenesis in which TCL1A enhances TCR signals and drives the accumulation of death-resistant memory-type cells that use amplified low-level stimulatory input, and whose loss of negative coregulators additionally maintains their activated state. Treatment rationales are provided by combined interception in TCR and survival signaling.